Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Laurent Chanroux
  • February 5, 2015
  • Articles

2015: a good year for psoriasis drug development?

2015: a good year for psoriasis drug development?

Psoriasis (PsO) is a chronic immune-mediated disease estimated to affect more than 125 million people worldwide.

Psoriasis (PsO) is a chronic immune-mediated disease estimated to affect more than 125 million people worldwide. The condition is characterised by thick and extensive skin lesions (plaques), which can cause itching, scaling, and pain. These symptoms can often negatively impact patients’ quality of life, both psychosocially and physically, making daily functioning more difficult and increasing the risk for other chronic illnesses. Although a number of treatment options exist for PsO, there continue to be significant unmet needs in the market

read more »